ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 705870 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 705870; 2) Community: the network communities that were significantly associated with the response to NSC 705870; 3) Molecule: the relationships between components within communities and NSC 705870; 4) MDR: the compounds that were significantly associated with the NSC 705870.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0385613993886001 0.26476134
NSC 726267 Null 0.0385613993886001 0.13750987
NSC 740 Methotrexate 0.0385613993886001 0.27834989
NSC 744063 Null 0.0385613993886001 0.13866292
NSC 756053 Null 0.0385613993886001 -0.070615964
NSC 758423 Amsacrine (USAN) 0.0385613993886001 0.2411757
NSC 759178 Pipamperone 0.0385613993886001 0.01115871
NSC 762559 Null 0.0385613993886001 -0.19387629
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0385613993886001 0.058267625
NSC 89074 Thiosulfuric acid (H2S2O3), -[2-[(5-cyclohexylpentyl)amino]ethyl] ester (9CI) 0.0385613993886001 0.019462813
Total:83  Current:69    [First] [Prev] [Next] [Last]